News + Filings Transactions Holdings
|
RA CAPITAL MANAGEMENT, L.P.
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Ascendis Pharma A/S
| ASND | SPONSORED ADR | 11,225,357 | 4,268,178 | 1,001,863,112,000 | 152,182,841,000 | 18.92 | |
Hist
| 06/30/2023 |
Legend Biotech Corp
| LEGN | SPONSORED ADR | 6,264,707 | 6,264,707 | 432,452,724,000 | 432,452,724,000 | 8.16 | |
Hist
| 06/30/2023 |
Vaxcyte, Inc.
| PCVX | SPONSORED ADS | 7,891,254 | 7,891,254 | 394,089,225,000 | 394,089,225,000 | 7.44 | |
Hist
| 06/30/2023 |
DICE Therapeutics, Inc.
| DICE | Common | 7,856,612 | 1,007,701 | 365,018,194,000 | 151,332,171,000 | 6.89 | 16.46 |
Hist
| 06/30/2023 |
89bio, Inc.
| ETNB | Common | 11,416,948 | 2,461,538 | 216,351,165,000 | 102,348,796,000 | 4.08 | |
Hist
| 06/30/2023 |
BIOGEN INC.
| BIIB | Common | 532,892 | 0 | 151,794,286,000 | 4,225,833,000 | 2.87 | |
Hist
| 06/30/2023 |
Aerovate Therapeutics, Inc.
| AVTE | Common | 8,263,982 | 0 | 141,727,291,000 | -100,407,382,000 | 2.68 | |
Hist
| 06/30/2023 |
Verona Pharma plc
| VRNA | Common | 6,317,990 | 6,317,990 | 133,562,309,000 | 133,562,309,000 | 2.52 | 0.99 |
Hist
| 06/30/2023 |
CureVac N.V.
| CVAC | Common | 12,245,955 | 12,245,955 | 127,602,851,000 | 127,602,851,000 | 2.41 | |
Hist
| 06/30/2023 |
Tyra Biosciences, Inc.
| TYRA | Common | 7,236,454 | 0 | 123,236,812,000 | 68,239,762,000 | 2.33 | 17.05 |
Hist
| 06/30/2023 |
NewAmsterdam Pharma Co N.V.
| NAMS | Common | 9,000,000 | 5,000,000 | 107,010,000,000 | 63,410,000,000 | 2.02 | 11.03 |
Hist
| 06/30/2023 |
Cytek Biosciences, Inc.
| CTKB | Common | 12,297,721 | -1,083,333 | 105,022,537,000 | -31,598,024,000 | 1.98 | 9.06 |
Hist
| 06/30/2023 |
Janux Therapeutics, Inc.
| JANX | Common | 8,670,644 | 0 | 102,920,544,000 | -11,271,837,000 | 1.94 | 20.73 |
Hist
| 06/30/2023 |
GERON CORP
| GERN | COM | 31,544,806 | 18,614,095 | 101,258,827,000 | 69,966,506,000 | 1.91 | 6.20 |
Hist
| 06/30/2023 |
Inhibrx, Inc.
| INBX | Common | 3,853,867 | 0 | 100,046,387,000 | 5,087,104,000 | 1.89 | 8.84 |
Hist
| 06/30/2023 |
RHYTHM PHARMACEUTICALS, INC.
| RYTM | Common | 5,676,067 | 160,000 | 93,598,345,000 | -67,029,526,000 | 1.77 | 10.00 |
Hist
| 06/30/2023 |
Day One Biopharmaceuticals, Inc.
| DAWN | Common | 7,809,852 | 769,230 | 93,249,633,000 | -58,264,552,000 | 1.76 | 10.62 |
Hist
| 06/30/2023 |
RxSight, Inc.
| RXST | Common | 3,052,796 | 0 | 87,920,525,000 | 49,241,600,000 | 1.66 | 8.98 |
Hist
| 06/30/2023 |
Cogent Biosciences, Inc.
| COGT | Common | 6,416,147 | 416,666 | 75,967,180,000 | 6,613,180,000 | 1.43 | 9.04 |
Hist
| 06/30/2023 |
PepGen Inc.
| PEPG | Common | 8,131,952 | 0 | 72,699,651,000 | -36,024,547,000 | 1.37 | 34.19 |
Hist
| 06/30/2023 |
Axsome Therapeutics, Inc.
| AXSM | COM | 1,000,000 | 1,000,000 | 71,860,000,000 | 71,860,000,000 | 1.36 | |
Hist
| 06/30/2023 |
Avidity Biosciences, Inc.
| RNA | Common | 6,416,998 | 962,465 | 71,164,508,000 | -49,871,579,000 | 1.34 | 9.06 |
Hist
| 06/30/2023 |
Vor Biopharma Inc.
| VOR | Common | 22,748,880 | 0 | 70,294,039,000 | -80,986,013,000 | 1.33 | 33.98 |
Hist
| 06/30/2023 |
GH Research PLC
| GHRS | Common | 5,587,333 | 688,960 | 66,293,706,000 | 18,681,520,000 | 1.25 | |
Hist
| 06/30/2023 |
Wave Life Sciences Ltd.
| WVE | Common | 17,202,009 | 0 | 62,615,313,000 | -57,798,750,000 | 1.18 | 17.53 |
Hist
| 06/30/2023 |
Acrivon Therapeutics, Inc.
| ACRV | Common | 4,810,508 | 0 | 62,344,184,000 | 6,927,132,000 | 1.18 | 21.94 |
Hist
| 06/30/2023 |
Icosavax, Inc.
| ICVX | Common | 5,963,565 | 0 | 59,218,200,000 | 11,867,494,000 | 1.12 | 14.40 |
Hist
| 06/30/2023 |
iTeos Therapeutics, Inc.
| ITOS | Common | 4,417,259 | 0 | 58,484,509,000 | -27,784,559,000 | 1.10 | 12.35 |
Hist
| 06/30/2023 |
4D Molecular Therapeutics, Inc.
| FDMT | Common | 3,069,531 | 3,069,531 | 55,466,425,000 | 55,466,425,000 | 1.05 | 9.23 |
Hist
| 06/30/2023 |
Mineralys Therapeutics, Inc.
| MLYS | Common | 3,178,476 | 3,178,476 | 54,193,016,000 | 54,193,016,000 | 1.02 | 7.78 |
Hist
| 06/30/2023 |
ALPINE IMMUNE SCIENCES, INC.
| ALPN | Common | 4,691,178 | 293,810 | 48,225,310,000 | 15,904,655,000 | 0.91 | 9.78 |
Hist
| 06/30/2023 |
Viridian Therapeutics, Inc.\DE
| VRDN | COM | 2,007,946 | 2,007,946 | 47,769,035,000 | 47,769,035,000 | 0.90 | 4.66 |
Hist
| 06/30/2023 |
Acumen Pharmaceuticals, Inc.
| ABOS | Common | 9,770,773 | 0 | 46,997,418,000 | -5,764,756,000 | 0.89 | 23.82 |
Hist
| 06/30/2023 |
Aclaris Therapeutics, Inc.
| ACRS | SPONSORED ADS | 4,398,453 | 4,398,453 | 45,611,958,000 | 45,611,958,000 | 0.86 | |
Hist
| 06/30/2023 |
ImmunoGen, Inc.
| IMGN | COM | 2,329,958 | -19,524,000 | 43,966,307,000 | -64,429,325,000 | 0.83 | 1.03 |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|